Acceder

Bibliografías temáticas / Hepatitis C / Artículos de revistas

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Hepatitis C.

Artículos de revistas sobre el tema "Hepatitis C"

Autor: Grafiati

Publicado: 4 de junio de 2021

Última modificación: 25 de julio de 2025

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Hepatitis C".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Nouman, Muhammad Khuram, Bushra Zaidi, Ghulam Mohiuddin, Faryal Asif, and Muhammad Khan Malik. "HEPATITIS C." Professional Medical Journal 25, no. 03 (2018): 387–91. http://dx.doi.org/10.29309/tpmj/2018.25.03.381.

Texto completo

Resumen

Background: Hepatitis C virus (HCV) is the most communal source of non-A,non-B viral hepatitis in the world. The disease is illusory, and the majority of patients do notacquire jaundice at its onset. Treatment of hepatitis C with interferon attained a sustainedvirological response (SVR) in almost 50% of the patients with HCV infection. Viral genotype isimportant to determine the response. The present study aims to provide the incidence of relapseof HCV in patients taking interferon therapy and to identify the predictors for relapse. StudyDesign: Retrospective observational study. Setting: Depa

Los estilos APA, Harvard, Vancouver, ISO, etc.

2

Jamali, Ghulam Mustafa, Anwar Ali Jamali, and Habibullah Shaikh. "HEPATITIS C VIRUS;." Professional Medical Journal 24, no. 11 (2017): 1621–29. http://dx.doi.org/10.29309/tpmj/2017.24.11.646.

Texto completo

Resumen

Objectives: The plan of this current research was in the direction for towards theassessment of the existing ELISA (Enzyme Linked Immunosorbant Assay) method throughantibodies testing for identification of hepatitis C virus disease by comparing their outcome withthe Real Time polymerase chain reaction analysis. Setting: Peoples Medical College HospitalNawabshah. Period: December 2015 to December 2016. Methods: In this current research 100blood samples were analyzed due to the presence of anti-HCV antibodies by 3rd-generationenzyme-linked immunosorbent assay testing. All the specimens were 100%

Los estilos APA, Harvard, Vancouver, ISO, etc.

3

Jain, Ravi, and Ashok Yadav. "Hepatitis B Versus Hepatitis C in Blood Donors." Annals of Applied Bio-Sciences 4, no. 1 (2017): A8—A13. http://dx.doi.org/10.21276/aabs.2017.1306.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

4

TARIQ, FAQIR MUHAMMAD, IRSHAD AHMAD, HABIB SUBHANI, and Irshad Ul Haq. "HEPATITIS C." Professional Medical Journal 16, no. 02 (2009): 169–72. http://dx.doi.org/10.29309/tpmj/2009.16.02.2890.

Texto completo

Resumen

I n t r o d u c t i o n : Hepatitis C is a RNA virus isolated in 1988 but still not cultured in the laboratory. Hepatitis-C infection is aserious global public health issue, WHO estimates worlds 3 % population is HCV positive. Pakistan is also facing the huge burden of thisdisease. Accurate prevalence information for hepatitis C infection is scant in Pakistan. Few population based studies are available, the mostcomprehensive being that of Luby et al which after testing a representative sample from a population of 150,000 in Hafizabad, Pakistanfound an overall sero-prevalence of 6%. This increa

Los estilos APA, Harvard, Vancouver, ISO, etc.

5

Billah, Mustansar, Syed Muhammad Raza Shah, and Muhammad Mujtaba Hashir. "HEPATITIS B AND HEPATITIS C." Professional Medical Journal 25, no. 08 (2018): 1245–51. http://dx.doi.org/10.29309/tpmj/18.4766.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

6

Salam, Abdul, Bilqis Aslam Baloch, Naseer Khan, Ghulam Sarwar, and Masoom ,. "SEROPREVALENCE OF HBsAg (HBS) AND ANTI-HCV." Professional Medical Journal 21, no. 04 (2018): 766–70. http://dx.doi.org/10.29309/tpmj/2014.21.04.2424.

Texto completo

Resumen

Background: Hepatitis is the inflammation of liver caused by infectious and noninfectiousagents. Hepatitis B and C are inflammations of liver caused by the viruses which are themajor public health problems worldwide and the incidence is even more in our country.Objective: Objective of the study was, 1). To estimate the prevalence of hepatitis B and hepatitisC viruses infected persons among the general population coming to BMC Hospital. 2). To pointout the more affected area of Baluchistan. 3). To produce awareness in the people. 4). To bringthis issue in Government notice. Method: The data was

Los estilos APA, Harvard, Vancouver, ISO, etc.

7

Huma Qureshi, Saeed Akhter, Hassan Mahmood, et al. "Overview of Hepatitis C Elimination Efforts in Pakistan and the Launch of Prime Minister’s Programme for the Elimination of Hepatitis C." Journal of the Pakistan Medical Association 74, no. 12 (2024): 2188–90. http://dx.doi.org/10.47391/jpma.24-97.

Texto completo

Resumen

Hepatitis B and C are serious viral infections that cancause liver damage and death. According to the WorldHealth Organization (WHO), there are currently 2.8 millionpeople living with hepatitis B in Pakistan, and 9.8 millionpeople living with hepatitis C.1 These numbers representa significant burden of disease for the country. Thecurrent prevalence of hepatitis B in Pakistan is 1.1%,which corresponds to one-quarter of the burden of thedisease in the Eastern Mediterranean region.1 Theprevalence of hepatitis C is 7.5%, which is the highest inthe world. Almost 37,000 people die each year in Pakis

Los estilos APA, Harvard, Vancouver, ISO, etc.

8

Viana, Daniel Rodrigues, Nathalia Mundoco Veloso, Osvaldo Carvalho Neto, Nicolas Garcia Papacosta, Gabriel Martins Nunes, and Virgílio Ribeiro Guedes. "Hepatite B e C: diagnóstico e tratamento." Revista de Patologia do Tocantins 4, no. 3 (2017): 73. http://dx.doi.org/10.20873/uft.2446-6492.2017v4n3p73.

Texto completo

Resumen

INTRODUÇÃO: As hepatites virais são consideradas as principais doenças hepáticas, podendo levar a quadros mais graves, como a cirrose e o carcinoma hepatocelular, tornando-se um importante problema de saúde pública. Tem distribuição global com áreas de altos índices de endemicidade, sobretudo em países asiáticos. Os principais agentes envolvidos são os vírus da hepatite A, B, C, D, E. O vírus da hepatite B e C se destacam nesse meio devido à grande capacidade de cronificação. As formas de transmissão são basicamente através do contato com fluidos corporais infectados, através de transfusões sa

Los estilos APA, Harvard, Vancouver, ISO, etc.

9

Vijendra, Singh Rawat, Ranjan Neelima, Jain Isha, and Bharat Jain Savita. "Hepatitis B and Hepatitis C - Seroprevalence and Correlation with C-Reactive Protein." International Journal of Pharmaceutical and Clinical Research 15, no. 6 (2023): 2003–8. https://doi.org/10.5281/zenodo.12529982.

Texto completo

Resumen

<strong>Background: </strong>Viral hepatitis caused by Hepatitis B(HBV) and Hepatitis C virus (HCV) is a major public health problem specially in developing countries like India. <strong>Materials and Methods: </strong>Three hundred blood samples were collected from patients having clinical sign and symptoms of hepatitis and apparently healthy pregnant females. Detection of hepatitis B surface antigen, antibodies against hepatitis C virus and C reactive protein (CRP) was done in these samples. <strong>Results:</strong> The seroprevalence of HBV and HCV in our study sam

Los estilos APA, Harvard, Vancouver, ISO, etc.

10

Andrade, Luís Jesuino, Paulo Melo, Isabel Lins, Raymundo Paraná, and Augusto Lins. "HEPATITIS C VIRUS AND HEPATITIS C-INFECTION." Brazilian Journal of Medicine and Human Health 3, no. 1 (2015): 19–28. http://dx.doi.org/10.17267/2317-3386bjmhh.v3i1.453.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

11

Moradpour and Blum. "Hepatitis C." Therapeutische Umschau 61, no. 8 (2004): 493–98. http://dx.doi.org/10.1024/0040-5930.61.8.493.

Texto completo

Resumen

Die Infektion mit dem Hepatitis C Virus (HCV) ist weltweit eine der häufigsten Ursachen der chronischen Hepatitis, Leberzirrhose und des hepatozellulären Karzinoms. In diesem Beitrag werden der aktuelle Stand und neue Entwicklungen auf dem Gebiet der Virologie, Diagnostik und Therapie der Hepatitis C zusammenfassend dargestellt. Die Standardtherapie der chronischen Hepatitis C mit pegyliertem Interferon-alpha und Ribavirin führt bei etwa 40–50% der Genotyp 1- und rund 80% der Genotyp 2 und 3-infizierten Patienten zur anhaltenden Viruselimination. Aufbauend auf einem verbesserten Verständnis de

Los estilos APA, Harvard, Vancouver, ISO, etc.

12

Khan, Momin, Abdul Jabbar, Bacha Amin Khan, Abdul Ahad, and Fazal Akbar. "HEPATITIS C." Professional Medical Journal 25, no. 04 (2018): 484–88. http://dx.doi.org/10.29309/tpmj/2018.25.04.332.

Texto completo

Resumen

Introduction: WHO estimates that there are more than 185 million people overthe globe infected with hepatitis C. Among these 350,000 die each year with hepatitis. Heprevalence of hepatitis in Asia is estimated to be 3.4%. Pakistan has been rated as the secondmost common country in the world with active hepatitis C infection. This study aims at identifyingthe frequency of risk factors for hepatitis C irus transmission. Understanding the frequency ofcommon factors of HCV would help to implement strategies in long-term prevention of hepatitistransmission among community. Objectives: To determine

Los estilos APA, Harvard, Vancouver, ISO, etc.

13

Calmet Schwartzmann, Fernando H., and Fernando H. Calmet Bruhn. "Hepatitis C." Diagnóstico 56, no. 1 (2018): 24–30. http://dx.doi.org/10.33734/diagnostico.v56i1.119.

Texto completo

Resumen

El virus de la hepatitis C (VHC) es un virus monocatenario ARN perteneciente al género Hepacivirus de la familia Flaviviridae. En la década de 1970, tras el descubrimiento de hepatitis Ay B, se hizo claro que había casos de hepatitis post-transfusión que no podían ser explicados por estos virus, llevando a la descripción de hepatitis "no A, no B". No fue hasta 1989 que se aisló el VHC por primera vez y entre 1990 y 1992 se desarrolló y refinó una prueba de anticuerpos anti-VHC que fue implementado en los bancos de sangre, llevando a una gran reducción de la transmisión de este virus a nivel mu

Los estilos APA, Harvard, Vancouver, ISO, etc.

14

Calmet Schwartzmamn, Fernando H., and Fernando H. Calmet Bruhn. "Hepatitis C." Diagnóstico 56, no. 1 (2020): 24–30. http://dx.doi.org/10.33734/diagnostico.v56i1.166.

Texto completo

Resumen

El virus de hepatitis C (VHC) es un virus monocatenario ARN perteneciente al género Hepacivirus de la familia Flaviviridae. En la década de 1970, tras el descubrimiento de hepatitis A y B, se hizo claro que había casos de hepatitis post-transfusión que no podían ser explicados por estos virus, llevando a la descripción de hepatitis ''no A, no B''. No fue hasta 1989 que se aisló el VHC por primera vez y emtre 1990 y 1992 se desarrolló y refinó una prueba de anticuerpos anti-VHC que fue implementado en los bancos de sangre, llevando a una gran reducción de la transmisión de este virus a nivel mu

Los estilos APA, Harvard, Vancouver, ISO, etc.

15

Icole, F., J. P. Bronowicki, C. Jeannoel, P. Besancon, and F. Boulanger. "Screening for hepatitis C in psychiatric population." European Psychiatry 64, S1 (2021): S90—S91. http://dx.doi.org/10.1192/j.eurpsy.2021.267.

Texto completo

Resumen

IntroductionA meta-analysis from 2016 estimates prevalence of hepatitis C to be superior in people with severe mental illness than general population. In France, positivity for hepatitis C is estimated at 0,75% of general population and 0.3% with a detectable viral load. No recent study was conducted to determine seroprevalence of hepatitis C in population admitted in psychiatric institution.ObjectivesThe aims of this study are to determine seroprevalence of hepatitis C in population admitted in psychiatric institution and describe the profile of infected patients.MethodsFrom january 2020 to o

Los estilos APA, Harvard, Vancouver, ISO, etc.

16

Shahbaz, Tazeem, Ghulam Farid, Raja Sajjad Asghar, and Abdul Rashid. "HEPATITIS B AND C." Professional Medical Journal 22, no. 11 (2015): 1383–89. http://dx.doi.org/10.29309/tpmj/2015.22.11.859.

Texto completo

Resumen

Background and Aims: The working conditions of Health care workers (HCW’S)expose them for a constant threat of contracting and spreading hepatitis B (HBV) and C virus(HCV) not only to their patients but family members as well. The aim of this study was to assessthe knowledge and attitude toward hepatitis B and C infection among the health-care workersand correlate the level of awareness to their behavior towards prevention of the disease. StudySettings: The study was conducted in Rashid Latif medical college and its two affiliated hospitals(Arif memorial teaching hospital and Hameed Latif Hosp

Los estilos APA, Harvard, Vancouver, ISO, etc.

17

Ball, Lynda K., and Jan Riordan. "Hepatitis C." American Journal of Nursing 100, no. 12 (2000): 13. http://dx.doi.org/10.2307/3522172.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

18

Rajan-Mohandas, N. "Hepatitis C." Pediatrics in Review 20, no. 9 (1999): 323. http://dx.doi.org/10.1542/pir.20-9-323.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

19

Jou, Janice H., and Andrew J. Muir. "Hepatitis C." Annals of Internal Medicine 148, no. 11 (2008): ITC6–1. http://dx.doi.org/10.7326/0003-4819-148-11-200806030-01006.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

20

Birmingham, Karen. "Hepatitis C." Inpharma Weekly &NA;, no. 1150 (1998): 3–4. http://dx.doi.org/10.2165/00128413-199811500-00003.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

21

Jou, Janice H., and Andrew J. Muir. "Hepatitis C." Annals of Internal Medicine 157, no. 11 (2012): ITC6–1. http://dx.doi.org/10.7326/0003-4819-157-11-201212040-01006.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

22

Nouman, Muhammad Khuram, Bushra Zaidi, Ghulam Mohiuddin, Faryal Asif, and Muhammad Khan Malik. "HEPATITIS C;." Professional Medical Journal 25, no. 03 (2018): 387–91. http://dx.doi.org/10.29309/tpmj/18.4065.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

23

Khan, Momin, Abdul Jabbar, Bacha Amin Khan, Abdul Ahad, and Fazal Akbar. "HEPATITIS C;." Professional Medical Journal 25, no. 04 (2018): 484–88. http://dx.doi.org/10.29309/tpmj/18.4293.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

24

Iqbal, Sajjad, Khalil-Ur Rahman, Muhammad Haroon Yousuf, and Nazish Jahan. "HEPATITIS C." Professional Medical Journal 22, no. 04 (2015): 432–38. http://dx.doi.org/10.29309/tpmj/2015.22.04.1321.

Texto completo

Resumen

Hepatitis C virus (HCV) has infected about 200 million individuals across theworld and is known as the major cause of liver disease . Objectives: Viral load measurementat early stages of the therapy in Hepatitis C patients is believed to be a more effective toolto predict the sustained virological response (SVR). The primary aim of the present studywas to evaluate whether the decline in viral load of HCV at early stages of the therapy maypredict the treatment response. Another objective was to see the benefits of therapy extensionin non-responders. Study Design: Descriptive, analytical study.

Los estilos APA, Harvard, Vancouver, ISO, etc.

25

KITCHLEW, RIZWANA, FUAD AHMAD SIDDIQI, and ASIF HASHMI. "HEPATITIS C;." Professional Medical Journal 19, no. 03 (2012): 375–81. http://dx.doi.org/10.29309/tpmj/2012.19.03.2149.

Texto completo

Resumen

Background: Liver biopsy the gold standard for the histological assessment in chronic hepatitis C is an invasive procedure withcertain limitations. Objective: It was to evaluate the relation of serum ALT levels with the histological changes in healthy blood donors screenedpositive for HCV. Study Design: This cross sectional comparative study Setting: It was conducted at department of medicine CombinedMilitary Hospital Lahore, from January to August 2004 Method: 76 apparently healthy blood donor soldiers age 20 – 49 years positive for HCVantibodies by third generation ELISA test, evaluated by m

Los estilos APA, Harvard, Vancouver, ISO, etc.

26

AHMED, WAHEED, SYED BADSHAH HUSSAIN ZAIDI, and MANZAR ZAKARIA. "HEPATITIS C." Professional Medical Journal 17, no. 01 (2010): 117–21. http://dx.doi.org/10.29309/tpmj/2010.17.01.2087.

Texto completo

Resumen

Objectives: To determine the frequency of thrombocytopenia and its manifestations in patients with Chronic Hepatitis C Virusinfection treated with interferon and ribavirin. Data Source: In door and out door patients. Design of Study: Case series. Setting and Periodof Study: Department of Medicine PNS Shifa Hospital Karachi, from 1s t August 2006 to 1s t July 2007. Materials and Methods: A Proformawas designed to enter the data of 100 patients fulfilling the inclusion criteria included in the study. Adult patients between the ages of 18 and50 years of both gender were selected. Presence of anti

Los estilos APA, Harvard, Vancouver, ISO, etc.

27

MEHMOOD KHAN, MUZAFFAR, Muhammad TAHIR, Mohsin RAZA, Muhammad Ali BHATTI, and Muhammad Riaz Khokar. "HEPATITIS ‘C’;." Professional Medical Journal 19, no. 02 (2012): 193–96. http://dx.doi.org/10.29309/tpmj/2012.19.02.2007.

Texto completo

Resumen

Objective: The objective of this study was to determine association of Interferon-Ribavarin therapy with hearing loss in patientssuffering from Hepatitis ‘C’. Study Design: Quasi-experimental study. Place and Duration: Otolaryngology Department Combined MilitaryHospital Rawalpindi from 09 June 2006 to 08 June 2007. Patients and Methods: Consenting sixty patients of Hepatitis C divided into two equalgroups of 30 each, (group A receiving Interferon-Ribavarin therapy and group B, not receiving it) during the study period fitting the inclusioncriteria were selected. Pure Tone Audiometery including

Los estilos APA, Harvard, Vancouver, ISO, etc.

28

CHAUDRY, NAYLA TARIQ, IMRANA IHSAN, WAHEED JAMEEL, and Sabiha Nasreen. "HEPATITIS - C." Professional Medical Journal 12, no. 04 (2005): 364–67. http://dx.doi.org/10.29309/tpmj/2005.12.04.5082.

Texto completo

Resumen

Objectives: 1) To evaluate the overall prevalence rate of viral hepatitiscarrier state among a group of voluntary blood donors. 2) To find the proportion of anti HCV in the study group. 3) Tofind the probable mode of transmission of HCV infection in the study group. Setting: Pathology lab, Jinnah Hospital,Iqra Medical Complex & Hi Tech Lab, Lahore. Period: November 2000 to April 2001. Patients & Methods: A total of890 apparently healthy blood donors (797 males, 93 females) were studied. Clinical details were recorded. The bloodsamples were collected using packed sterile disposable syri

Los estilos APA, Harvard, Vancouver, ISO, etc.

29

Rajan-Mohandas, Niranjana. "Hepatitis C." Pediatrics In Review 20, no. 9 (1999): 323. http://dx.doi.org/10.1542/pir.20.9.323.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

30

Eames, Jennifer R., and Bau Tran. "Hepatitis C." Physician Assistant Clinics 6, no. 4 (2021): 555–68. http://dx.doi.org/10.1016/j.cpha.2021.05.002.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

31

Foster, Graham. "Hepatitis C." Drugs in Context 4 (2007): 1. http://dx.doi.org/10.7573/dic.212201.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

32

Wong, John B. "Hepatitis C." PharmacoEconomics 24, no. 7 (2006): 661–72. http://dx.doi.org/10.2165/00019053-200624070-00005.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

33

Malpas, Michael. "Hepatitis C." Nursing Standard 25, no. 37 (2011): 59. http://dx.doi.org/10.7748/ns2011.05.25.37.59.c8522.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

34

Dawson, Stacey, and Emma Meader. "Hepatitis C." InnovAiT: Education and inspiration for general practice 11, no. 2 (2018): 101–8. http://dx.doi.org/10.1177/1755738017740161.

Texto completo

Resumen

Hepatitis C virus (HCV) infection affects approximately 180 000 000 people worldwide, with the highest rates reported in Africa and Asia. In the UK, the rate is in the region of 1% of the population. Most infections become chronic and can lead to extensive liver damage and hepatocellular carcinoma. Despite recent advances in treatment strategies the high cost, high demand, screening uptake and re-infection rates make HCV one of the greatest healthcare challenges of modern medicine. This article provides an overview of HCV and aims to equip GPs for their role in screening and management in prim

Los estilos APA, Harvard, Vancouver, ISO, etc.

35

Hepworth, Julie, and Gary J. Krug. "Hepatitis C." Journal of Health Psychology 4, no. 2 (1999): 237–46. http://dx.doi.org/10.1177/135910539900400216.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

36

Belville-Robertson, T. L., L. R. Clemensen, and A. K. Eshelman. "HEPATITIS C." Psychosomatic Medicine 61, no. 1 (1999): 87. http://dx.doi.org/10.1097/00006842-199901000-00031.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

37

Lavanchy, Daniel, and Pilar Gavinio. "Hepatitis C." Canadian Journal of Gastroenterology 14, suppl b (2000): 67B—77B. http://dx.doi.org/10.1155/2000/630301.

Texto completo

Resumen

Hepatitis C has been identified as the most common cause of post-transfusion hepatitis worldwide, accounting for approximately 90% of this disease in Japan, the United States and Western Europe. Hepatitis C is a major global public health problem. New infections continue to occur, and the source of infection includes transfusion of blood or blood products from unscreened donors; transfusion of blood products that have not undergone viral inactivation; parenteral exposure to blood through use of contaminated and inadequately sterilized instruments and needles used in medical, dental and ‘tradit

Los estilos APA, Harvard, Vancouver, ISO, etc.

38

Halsey, NA. "Hepatitis C." Nurse Practitioner 23, no. 6 (1998): 148. http://dx.doi.org/10.1097/00006205-199806000-00021.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

39

Jenny-Avital, Elizabeth R. "Hepatitis C." Current Opinion in Infectious Diseases 11, no. 3 (1998): 293–300. http://dx.doi.org/10.1097/00001432-199806000-00005.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

40

Walsh, Kieran. "Hepatitis C." BMJ 328, no. 7451 (2004): 1296. http://dx.doi.org/10.1136/bmj.328.7451.1296.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

41

Sarbah, Steedman A., and Zobair M. Younossi. "Hepatitis C." Journal of Clinical Gastroenterology 30, no. 2 (2000): 125–43. http://dx.doi.org/10.1097/00004836-200003000-00005.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

42

Zweben, Joan E. "Hepatitis C." Journal of Addictive Diseases 20, no. 1 (2001): 33–42. http://dx.doi.org/10.1300/j069v20n01_04.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

43

Moore, Grace A., Diane A. Hawley, and Pat Bradley. "Hepatitis C." Gastroenterology Nursing 32, no. 2 (2009): 94–104. http://dx.doi.org/10.1097/sga.0b013e31819de48b.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

44

Burra, Patrizia. "Hepatitis C." Seminars in Liver Disease 29, no. 01 (2009): 053–65. http://dx.doi.org/10.1055/s-0029-1192055.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

45

PARINI, SUE. "Hepatitis C." Nursing 33, no. 4 (2003): 57–64. http://dx.doi.org/10.1097/00152193-200304000-00040.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

46

Dusheiko, Geoffrey. "Hepatitis C." Medicine 30, no. 11 (2002): 37–40. http://dx.doi.org/10.1383/medc.30.11.37.28454.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

47

Ball, Lynda K. "HEPATITIS C." American Journal of Nursing 100, no. 12 (2000): 13. http://dx.doi.org/10.1097/00000446-200012000-00003.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

48

Riordan, Jan. "HEPATITIS C." American Journal of Nursing 100, no. 12 (2000): 13. http://dx.doi.org/10.1097/00000446-200012000-00004.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

49

Bockhold, Kathleen. "HEPATITIS C." American Journal of Nursing 100, no. 12 (2000): 13. http://dx.doi.org/10.1097/00000446-200012000-00005.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

50

Marengo-Rowe, Alain J. "Hepatitis C." Baylor University Medical Center Proceedings 3, no. 4 (1990): 3–12. http://dx.doi.org/10.1080/08998280.1990.11929728.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!